How to Get Pomalyst (Pomalidomide) Covered by Cigna in North Carolina: Complete 2025 Guide with Forms and Appeal Scripts
Answer Box: Getting Pomalyst Covered by Cigna in North Carolina
Cigna covers Pomalyst (pomalidomide) for multiple myeloma with prior authorization after at least one prior regimen including lenalidomide and/or a proteasome inhibitor. Medicare Advantage plans list it as Tier 4 specialty; commercial plans require PA and often step therapy. If denied, use Cigna's internal appeals (180 days for commercial, 65 days for Medicare), then North Carolina's Smart NC external review within 4 months.
First step today: Call Cigna at the number on your card to confirm formulary status and request PA forms. Have your oncologist document prior therapies and progression dates.
Table of Contents
- Coverage Basics: Is Pomalyst Covered?
- Prior Authorization Process
- Timing and Urgency
- Clinical Criteria and Step Therapy
- Costs and Coverage Tiers
- Denials and Appeals
- Renewals and Re-authorization
- Specialty Pharmacy Requirements
- Common Problems and Solutions
- Frequently Asked Questions
Coverage Basics: Is Pomalyst Covered?
Cigna Medicare Advantage Plans
Pomalyst (pomalidomide) is covered on Cigna's 2025 Medicare formularies including Enhanced, Standard, and Basic plans as a Tier 4 specialty drug. Coverage includes:
- Prior authorization required (PA)
- Quantity limits (typically 168 capsules per 28 days)
- Limited availability (LA) at select specialty pharmacies
- High-risk medication (HRM) designation requiring additional monitoring
Cigna Commercial Plans
Commercial employer-sponsored plans typically cover Pomalyst as a specialty tier medication with:
- Prior authorization requirements
- Step therapy protocols
- Higher copays or coinsurance (20-50%)
- Specialty pharmacy network restrictions
Note: Coverage varies by specific employer plan. Check your Summary of Benefits or call Cigna member services for exact details.
Prior Authorization Process
Who Submits the PA Request
Your oncologist or prescribing physician must submit the prior authorization request. Patients cannot submit PA requests directly, but you can help gather required documentation.
Required Documentation
According to Cigna's oncology PA policy, the following must be included:
Clinical Information:
- Patient age (≥18 years required)
- Multiple myeloma diagnosis with staging
- Documentation of at least one prior myeloma regimen
- Prior therapy timeline with dates and outcomes
- Current disease status and treatment goals
Prior Therapy Documentation:
- Lenalidomide-based regimens (dates, duration, response)
- Proteasome inhibitor exposure (bortezomib, carfilzomib, ixazomib)
- Reason for discontinuation (progression, toxicity, intolerance)
- Imaging or lab results showing disease progression
How to Submit
For Medicare Advantage:
- Call the prior authorization number on your ID card
- Submit via Cigna provider portal
- Fax completed forms to the number specified for your plan
For Commercial Plans:
- Use Cigna's online provider portal
- Call 1-855-242-4642 for PA requests
- Fax to the prior authorization department (number on denial letter)
Timing and Urgency
Standard PA Timeline
- Medicare Advantage: Up to 72 hours for standard requests
- Commercial: Within 72 hours for pre-service requests
- Expedited requests: Within 24 hours when delay could harm health
When to Request Expedited Review
Request urgent processing if:
- Disease is rapidly progressing
- Patient has limited treatment options remaining
- Delay could compromise planned interventions (transplant, CAR-T therapy)
Tip: Have your oncologist explicitly state in writing that the case is urgent and explain the medical risks of delay.
Clinical Criteria and Step Therapy
Cigna's Requirements for Pomalyst
Based on Cigna's coverage policy:
| Requirement | Details | Documentation Needed |
|---|---|---|
| Age | ≥18 years | Date of birth verification |
| Diagnosis | Multiple myeloma | Pathology report, staging |
| Prior Therapy | At least one prior regimen | Treatment timeline with dates |
| Line of Therapy | Relapsed/refractory disease | Progression documentation |
| Combination | Usually with dexamethasone | Planned regimen details |
What Counts as Prior Therapy
Acceptable prior regimens include:
- Lenalidomide-based combinations (Revlimid + dexamethasone ± other agents)
- Proteasome inhibitor regimens (bortezomib, carfilzomib, ixazomib-based)
- Monoclonal antibody combinations (daratumumab-based regimens)
- Standard induction regimens prior to autologous transplant
Costs and Coverage Tiers
Medicare Advantage Cost-Sharing
For Tier 4 specialty drugs like Pomalyst:
- Deductible phase: You pay full cost until plan deductible is met
- Initial coverage: Typically 25-33% coinsurance
- Coverage gap: Reduced coinsurance under Inflation Reduction Act
- Catastrophic phase: $0 after $2,100 out-of-pocket in 2025
Commercial Plan Costs
- Specialty tier copay: Often $100-500 per month
- Coinsurance: Typically 20-50% of drug cost
- Annual out-of-pocket maximum: Varies by plan (often $3,000-8,000)
Financial Assistance Options
- Bristol Myers Squibb Access Support: Patient assistance programs and copay cards
- Foundation grants: Leukemia & Lymphoma Society, Patient Advocate Foundation
- Medicare Extra Help: Low-income subsidy reducing costs to $0-10.20
Denials and Appeals
Common Denial Reasons and Solutions
| Denial Reason | How to Fix | Required Documentation |
|---|---|---|
| Missing prior therapy | Document all previous treatments | Pharmacy records, clinic notes |
| Step therapy not met | Show progression on required agents | Imaging, labs, progression notes |
| Non-specialist prescriber | Transfer to oncologist/hematologist | Specialist consultation |
| REMS not complete | Enroll in POMALYST REMS program | REMS enrollment confirmation |
| Not medically necessary | Provide clinical guidelines support | NCCN guidelines, peer-reviewed studies |
Internal Appeals with Cigna
Commercial Plans:
- Deadline: 180 days from denial date
- Timeline: Decision within 30 days (72 hours if urgent)
- Address: Use address on denial letter or submit via member portal
Medicare Advantage:
- Deadline: 65 days from coverage determination
- Timeline: 72 hours for standard, 24 hours for expedited
- Method: Call, fax, mail, or online submission
North Carolina External Review
If Cigna upholds the denial after internal appeals, North Carolina residents can request external review through Smart NC.
Smart NC Process:
- Call Smart NC: 1-855-408-1212 (toll-free)
- Timeline: Request within 4 months of final Cigna denial
- Decision time: 45 days standard, 72 hours expedited
- Cost: Free to consumers
- Binding: IRO decision is binding on Cigna
From our advocates: We've seen multiple myeloma patients successfully overturn Cigna denials through Smart NC when they provided comprehensive documentation of prior therapy failures and current disease progression. The key is having your oncologist clearly explain why formulary alternatives are no longer appropriate for your specific case.
Renewals and Re-authorization
When to Renew
- Initial approval: Typically granted for 6-12 months
- Renewal timing: Submit 30 days before expiration
- Required updates: Current disease status, treatment response, toxicity assessment
Documentation for Renewal
- Recent imaging or lab results
- Treatment response assessment
- Toxicity monitoring results
- Continued medical necessity justification
Specialty Pharmacy Requirements
REMS Program Enrollment
Pomalyst requires enrollment in the PS-Pomalidomide/POMALYST REMS program:
- Prescriber certification in REMS program
- Patient enrollment and signed agreement
- Pregnancy testing for females of reproductive potential
- Contraception requirements for all patients
Cigna Specialty Pharmacies
For Cigna members, Pomalyst is typically dispensed through:
- Accredo Specialty Pharmacy (Cigna's preferred specialty pharmacy)
- Other REMS-certified specialty pharmacies in network
Common Problems and Solutions
Portal Issues
- Problem: Cigna portal down or forms not loading
- Solution: Call member services or fax forms directly
Missing Documentation
- Problem: PA denied for incomplete information
- Solution: Request specific list of missing items and resubmit
REMS Delays
- Problem: REMS enrollment holding up approval
- Solution: Contact BMS Access Support for REMS assistance
Pharmacy Transfer Issues
- Problem: Local pharmacy can't fill Pomalyst
- Solution: Transfer to Cigna-approved specialty pharmacy
Frequently Asked Questions
Q: How long does Cigna PA take in North Carolina? A: Standard requests: 72 hours. Expedited requests when medically urgent: 24 hours.
Q: What if Pomalyst is non-formulary on my plan? A: Request a formulary exception with clinical justification showing why covered alternatives won't work.
Q: Can I request an expedited appeal? A: Yes, if delay could seriously harm your health. Your oncologist must document the urgency.
Q: Does step therapy apply if I failed treatments outside North Carolina? A: Yes, prior therapy documentation from any location counts toward step therapy requirements.
Q: What happens if I miss a renewal deadline? A: You may need to restart the PA process. Submit renewal requests 30 days early to avoid gaps.
Q: Can family members help with appeals? A: Yes, with proper authorization forms allowing them to speak with Cigna on your behalf.
About Counterforce Health
Counterforce Health specializes in turning insurance denials into successful approvals through evidence-based appeals. Our platform analyzes denial letters, identifies specific policy requirements, and generates targeted appeals with the right clinical evidence and procedural compliance. We help patients, clinicians, and specialty pharmacies navigate complex prior authorization requirements and appeal processes for specialty medications like Pomalyst.
Sources and Further Reading
- Cigna Pomalyst Prior Authorization Policy (PDF)
- Cigna Medicare Formulary 2025
- POMALYST REMS Program Information
- North Carolina Smart NC External Review
- Cigna Member Appeals Process
- BMS Access Support for Pomalyst
This guide provides general information about insurance coverage and appeal processes. It is not medical advice. Always consult with your healthcare provider about treatment decisions and work with them to navigate insurance requirements. For personalized assistance with North Carolina insurance issues, contact Smart NC at 1-855-408-1212.
Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.